作为钙离子渗透性的瞬时受体电位（TRP），5种通道（TRPV1~4和TRPM2）被不同的高温激活，两种通道（TRPV1和TRPV8）被低温激活。越来越多的证据表明，TRPA1和TRPM8拮抗剂可预防顺铂、奥沙利铂和紫杉醇诱导的线粒体氧化应激、炎症、冷痛和痛觉过敏。TRPV1在顺铂引起的感觉神经元热痛觉和机械异常中有应答。TRPA1、TRPM8和TRPV2蛋白表达水平主要通过这些治疗方法在背根（DRG）和三叉神经节中增加。主要总结了5种温度调节TRP通道（TRPA1、TRPM8、TRPV1、TRPV2和TRPV4）。

As members of the Ca²⁺ permeable transient receptor potential (TRP), five of the channels (TRPV1-4 and TRPM2) are activated by different heat temperatures, and two of the channels (TRPA1 and TRPM8) are activated by cold temperature. Accumulating evidences indicates that antagonists of TRPA1 and TRPM8 may protect against cisplatin, oxaliplatin, and paclitaxel-induced mitochondrial oxidative stress, inflammation, cold allodynia, and hyperalgesia. TRPV1 is responsible from the cisplatin-induced heat hyperalgesia and mechanical allodynia in the sensory neurons. TRPA1, TRPM8, and TRPV2 protein expression levels are mostly increased in the dorsal root (DRG) and trigeminal ganglia by these treatments. Five temperature-regulated TRP channels (TRPA1, TRPM8, TRPV1, TRPV2, and TRPV4) as novel targets for treating chemotherapy-induced neuralgia are summarized in this review.

国家自然科学基金资助项目（81601153）；江苏省自然科学基金资助项目（BK20150104）；南京市医学科技发展基金资助项目（YKK16083）；南京市科技发展计划项目（201503020）